We are live on ! Find out more
BCM

Bronte Capital Management Portfolio holdings

AUM $1.01B
1-Year Est. Return 47.99%
This Fund
S&P 500
This Quarter Est. Return
-16.28%
1 Year Est. Return
+47.99%
3 Year Est. Return
+112.22%
5 Year Est. Return
+138.3%
10 Year Est. Return
–
AUM
$873M
AUM Growth
-$318M
Cap. Flow
+$117M
Cap. Flow %
13.43%
Top 10 Hldgs %
72.8%
Holding
33
New
2
Increased
20
Reduced
9
Closed
1

Top Buys

Rank Stock Value
1
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$115M
2
IBB icon
iShares Biotechnology ETF
IBB
+$33.7M
3
V icon
Visa
V
+$28.1M
4
BNY
Bank of New York Mellon
BNY
+$15.4M
5
ALB icon
Albemarle
ALB
+$12.2M

Top Sells

Rank Stock Value
1
BBWI icon
Bath & Body Works
BBWI
+$11.5M
2
MO icon
Altria Group
MO
+$2.95M
3
SHC icon
Sotera Health
SHC
+$1.95M
4
MDLZ icon
Mondelez International
MDLZ
+$1.44M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$1.12M

Sector Composition

Rank Sector Weight
1 Financials 29.08%
2 Communication Services 20.02%
3 Consumer Staples 12.39%
4 Healthcare 12.25%
5 Materials 8.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MACK
26
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$3.44M 0.39%
578,313
– –
BBWI icon
27
Bath & Body Works
BBWI
$4.06B
$3.23M 0.37%
119,878
-264,954
-69% -$11.5M
NEM icon
28
Newmont
NEM
$98.7B
$3.14M 0.36%
52,574
+2,379
+5% +$168K
NPO icon
29
Enpro
NPO
$6.63B
$2.51M 0.29%
30,631
+61
+0.2% +$5.69K
AVLR
30
DELISTED
Avalara, Inc.
AVLR
$1.98M 0.23%
27,975
+15,184
+119% +$1.25M
BNTX icon
31
BioNTech
BNTX
$22.9B
$1.04M 0.12%
6,948
+14
+0.2% +$2.14K
DBTX
32
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
$689K 0.08%
163,547
+323
+0.2% +$763
XBI icon
33
CALL
State Street SPDR S&P Biotech ETF
XBI
$9.95B
– –
-120,000
Closed -$10.8M
1
2

Similar funds

EPAM
Euro Pacific Asset Management Dorado, Puerto Rico $1.01B AUM 79.26% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
GA
GRS Advisors Chicago, Illinois $1.01B AUM 13.12% 1-Year Est. Return
CT
Coastline Trust Providence, Rhode Island $1.01B AUM 22.57% 1-Year Est. Return
AH
Allen Holding New York $1.01B AUM 27.61% 1-Year Est. Return
PIM
Provident Investment Management Novi, Michigan $1.01B AUM 9.4% 1-Year Est. Return
WA
Wealth Alliance Mellville, New York $1.01B AUM 19.71% 1-Year Est. Return
MIM
Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return

Bronte Capital Management's Q2 2022 Portfolio in Review

As of Q2 2022, Bronte Capital Management held 33 positions worth $873M, down 27% from $1.19B the previous quarter. Its ten largest holdings account for 73% of the portfolio.

Bronte Capital Management deployed $117M of net new capital in Q2 2022, opening 2 new positions and adding to 20 existing holdings. Its largest new stake was iShares Biotechnology ETF: 284,269 shares worth $33.4M.

By sector, the portfolio is most concentrated in Financials at 29% of assets, up from 7.7% a quarter earlier, followed by Communication Services and Consumer Staples.

On the sell side, the largest reduction was Bath & Body Works, an estimated $11.5M trimmed.

  • Bronte Capital Management's largest Q2 2022 buy was iShares Biotechnology ETF: 284,269 shares worth $33.4M.
  • Bronte Capital Management added most to Berkshire Hathaway Class B in Q2 2022, an estimated $115M increase.
  • Bronte Capital Management's biggest Q2 2022 reduction was Bath & Body Works, cutting an estimated $11.5M.
  • Bronte Capital Management's ten largest holdings make up 73% of its $873M portfolio in Q2 2022.
  • Bronte Capital Management opened 2 new positions and closed 1 in Q2 2022.
  • Bronte Capital Management's portfolio value fell 27% quarter-over-quarter to $873M.

Based on Bronte Capital Management's 13F filing for Q2 2022, filed 8 Aug 2022.